White House Touts Trump's Marijuana Rescheduling Order As A Top 'Win' During His First Year Back In Office – Marijuana Moment
White House Touts Trump’s Marijuana Rescheduling Order As A Top ‘Win’ During His First Year Back In Office
ATF Moves To Loosen Gun Ban For People Who’ve Used Marijuana Or Other Illegal Drugs
South Carolina Lawmakers Should Pass Hemp Legislation That Smartly Regulates Products (Op-Ed)
Florida Lawmakers Approve Bill To Ban Public Marijuana Smoking Ahead Of Possible Legalization Vote On The Ballot
Attorney General Misses Deadline For Rules To Make It Easier To Study Schedule I Drugs Like Marijuana And Psychedelics
Marijuana’s Restrictive Federal Classification Isn’t Supported By Science, New Study Concludes
USDA Study Shows Untapped Potential Of Hemp Roots In Pediatric Cancer Treatment
More Than A Third Of Rap And Hip Hop Music Videos Feature Marijuana, Government-Funded Study Shows
CBD Has ‘Substantial Promise’ To Combat Tumors From Cancer, Scientific Review Shows
Marijuana Users Are Being Unjustly Jailed For Allegedly Driving Under The Influence, Government-Funded Study Shows
State Marijuana Regulators Share Tips On How To Stay Safe And Legal Around The Holidays
One In Three Americans ‘Pre-Game’ With Marijuana Before Family Holiday Gatherings, Survey Finds
As More Americans Choose Marijuana Over Alcohol, Mainstream Media Notices The ‘Cousin Walk’ Thanksgiving Tradition
Joe Rogan Slams ‘Really Bad’ Federal Hemp Ban Trump Signed, Blaming Alcohol Industry For Influencing Congress
New Netflix Documentary Shows How Psychedelics Help Military Veterans Heal Trauma
Montana Retailers Have Sold More Than $1 Billion Worth Of Recreational Marijuana Since Legalization Took Effect
Pre-Rolls Are A Key Driver Of The Cannabis Retail Market’s Success (Op-Ed)
Massachusetts Hits $10 Billion Marijuana Sales Milestone, With Top Official Saying Consumption Lounges Will Bolster Industry In 2026
Ohio Dispensaries Sold More Than $1 Billion Worth Of Legal Marijuana In 2025
Marijuana Consumers Are More Likely To Shop At Target Following Decision To Sell Cannabis-Infused Drinks, Poll Shows
AG misses cannabis & psychedelics research rule deadline (Newsletter: January 21, 2026)
Feds tout hemp roots’ potential in kids’ cancer treatment (Newsletter: January 20, 2026)
Senators push to delay federal hemp THC ban (Newsletter: January 19, 2026)
GOP senators try to stop Trump’s cannabis rescheduling (Newsletter: January 16, 2026)
Ohio AG rejects cannabis referendum ballot petition (Newsletter: January 15, 2026)
Published
on
By
The White House is holding up President Donald Trump’s executive order directing federal agencies to complete the process of marijuana rescheduling as an example of one of his “wins” during his first year back in office.
“In just 365 days, President Trump has delivered truly transformative results with the most accomplished first year of any presidential term in modern history,” a new article posted on the White House website on Tuesday says. It then goes on to list “365 wins from President Trump’s first 365 days back in office.”
Number 305 on the list reads: “Signed an executive order reclassifying marijuana to Schedule III, accelerating medical research and patient access.”
The cannabis item is included in a section titled, “Making America Healthy Again.”
While the White House is touting Trump’s signing of the order last month directing Attorney General Pam Bondi to expeditiously complete the process of moving marijuana from Schedule I of the Controlled Substances Act (CSA) to Schedule III, that has not yet occurred.
365 WINS IN 365 DAYS: President Trump’s Return Marks New Era of Success, Prosperityhttps://t.co/0z5vzUav6t
— Karoline Leavitt (@PressSec) January 20, 2026
DOJ has so far not provided any updates or timelines on the rescheduling process since Trump issued his executive order last month, and Attorney General Pam Bondi—who has historically opposed marijuana reform—was not present at the signing ceremony.
A Democratic senator told Marijuana Moment last week that it’s “too early to tell” what the implications of Trump’s cannabis order will be—saying that while there are “things that look promising” about it, he is “very concerned about where the DOJ will land.”
“The ability of the Trump administration to speak out of both sides of their mouth is staggering,” Sen. Cory Booker (D-NJ) said. “So I’m just going to wait and see right now. Obviously, there’s things that look promising—to end generations of injustice. I really want to wait and see.”
Last week, two other GOP senators filed an amendment to block the Trump administration from rescheduling cannabis, but it was not considered on the floor.
Meanwhile, earlier this month, the Drug Enforcement Administration (DEA) said a marijuana rescheduling appeal process “remains pending” despite Trump’s executive order.
A recent Congressional Research Service (CRS) report discussed how DOJ could, in theory, reject the president’s directive or delay the process by restarting the scientific review into marijuana.
Bondi separately missed a congressionally mandated deadline last week to issue guidelines for easing barriers to research on Schedule I substances such as marijuana and psychedelics.
Tom Angell is the editor of Marijuana Moment. A 25-year veteran in the cannabis and drug law reform movement, he covers the policy and politics of marijuana, psychedelics and other substances. He previously reported for Forbes, Marijuana.com and MassRoots, and was given the Hunter S. Thompson Media Award by NORML and has been named Journalist of the Year by Americans for Safe Access. As an activist, Tom founded the nonprofit Marijuana Majority and handled media relations, campaigns and lobbying for Law Enforcement Against Prohibition and Students for Sensible Drug Policy.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2026 Marijuana Moment LLC ® and Tom Angell
